CIVITERA/Contact
Engage CIVITERA

Speak with
the house.

All inquiries are routed to the relevant CIVITERA division and treated as confidential. For licensing, governance, partnership, or general matters, the appropriate channel is below.

Three Engagement Paths

Choose the path that fits your inquiry.

Most engagements with CIVITERA fall into one of three categories. Selecting the right path routes your inquiry to the appropriate channel and accelerates response.

Direct Channels

Reach the right division.

01 / Licensing

Licensing & Partnerships

For exclusive, non-exclusive, field-of-use, joint-development, and sovereign-deployment inquiries across the CIVITERA crown estate.

partners@civitera.ai →
02 / Governance

Governance & Sovereignty

For sovereign agencies, governance frameworks, cross-jurisdiction engagement, and policy-layer discussion.

governance@civitera.ai →
03 / General

General Inquiries

For press, prospective investors, academic engagement, and general correspondence with the office.

info@civitera.ai →
04 / Research

Research & Technical

For research collaboration, technical engagement, and questions on patent specifications or claim architecture.

research@civitera.ai →
The Entity

CIVITERA GovTech Inc.

A United States C-Corporation registered in the State of Delaware, filing under United States Patent and Trademark Office Micro Entity status (37 CFR §1.29). Correspondence is received at the Delaware office of record.

Legal Name
CIVITERA GovTech Inc.
Jurisdiction
State of Delaware, United States
Entity Type
C-Corporation
USPTO Status
Registered Filer · Micro Entity (37 CFR §1.29)
Correspondence
254 Chapman Rd, Ste 208 #26511
Newark, DE 19702
United States of America
Established
2026
General Inquiry

Send a confidential message.

Use this form for general correspondence. For structured licensing inquiries, please use the licensing inquiry form.

Submitting opens a pre-filled message to the selected division. CIVITERA does not store form submissions on this site.

Engagement Policy

How we respond.

01 / Triage

Routed within 48 hours

Every inquiry is reviewed and routed to the appropriate division within two business days of receipt.

02 / Priority

Licensing prioritized

Licensing, partnership, and government inquiries are prioritized in the response queue.

03 / Confidentiality

NDA-ready

Sensitive engagements proceed under mutual non-disclosure prior to portfolio-level disclosure.